| 2024-07-24 | -28.6% | legal | SEC EDGAR | EW 8-K: 2.02, 7.01and8.01 (SEC Filing) |
| 2022-10-27 | -20.1% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2023-07-26 | -9.2% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2023-10-25 | -8.3% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2022-07-28 | -7.5% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2025-02-11 | +6.9% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2022-01-26 | -6.1% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2022-04-26 | -5.7% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-04-08 | -5.2% | earnings | MarketBeat | Rathbones Group PLC Has $1.42 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-08 | -5.2% | earnings | MarketBeat | Sivik Global Healthcare LLC Acquires New Shares in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-09 | -5.2% | executive | Investing.com | Edwards Lifesciences’ CFO Ullem sells $1m in shares - Investing.com |
| 2026-04-09 | -5.2% | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) CFO Sells $1,040,520.00 in Stock - MarketBeat |
| 2026-04-09 | -5.2% | news | GuruFocus | Edwards Lifesciences Corp (EW) Stock Down 3.1% -- Now Undervalued? GF Score: 98/100 - GuruFocus |
| 2026-04-09 | -5.2% | executive | Stock Titan | Edwards Lifesciences (NYSE: EW) CFO trades 13K shares under 10b5-1 plan - Stock Titan |
| 2025-10-25 | +5.0% | analyst | TIKR.com | Edwards Lifesciences Stock Forecast: Where Analysts See the Stock Going by 2027 - TIKR.com |
| 2026-02-20 | +4.8% | analyst | TIKR.com | Edwards Lifesciences Stock at $78: Here’s the Analysts’ Bull Case Scenario - TIKR.com |
| 2025-08-19 | +4.8% | legal | SEC EDGAR | EW 8-K: 8.01 and (SEC Filing) |
| 2026-02-26 | +4.7% | news | Seeking Alpha | Edwards Lifesciences Corporation (EW) Presents at Citi's 2026 Unplugged MedTech and Life Sciences Access Day Transcript |
| 2026-02-26 | +4.7% | analyst | Yahoo Finance | How The Edwards Lifesciences (EW) Investment Story Is Shifting After Mixed Analyst Revisions - Yahoo Finance |
| 2023-01-31 | +4.6% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2024-07-15 | -4.5% | legal | SEC EDGAR | EW 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-03-09 | +4.4% | analyst | Yahoo Finance | Is Edwards Lifesciences Stock Outperforming the S&P 500? - Yahoo Finance |
| 2026-02-06 | -4.1% | news | Yahoo Finance | Is Edwards Lifesciences (EW) Share Weakness Creating A Valuation Opportunity? - Yahoo Finance |
| 2026-02-23 | +3.6% | news | Yahoo Finance | Here is Why Edwards Lifesciences Corporation (EW) Looks Attractive - Yahoo Finance |
| 2026-02-10 | +3.6% | earnings | Seeking Alpha | Edwards Lifesciences Non-GAAP EPS of $0.58 misses by $0.04, revenue of $1.57B beats by $30M |
| 2026-02-10 | +3.6% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-02-10 | +3.6% | earnings | Quiver Quantitative | Edwards Lifesciences (EW) Stock Falls on Q4 2025 Earnings - Quiver Quantitative |
| 2026-02-10 | +3.6% | earnings | Yahoo Finance | Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics - Yahoo Finance |
| 2025-07-24 | +3.6% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-02-17 | +3.4% | legal | Seeking Alpha | Edwards Lifesciences gains as Europe drops antitrust investigation |
| 2026-02-16 | +3.2% | news | Yahoo Finance | Edwards Lifesciences Corporation (NYSE:EW) is a favorite amongst institutional investors who own 88% - Yahoo Finance |
| 2026-02-15 | +3.2% | earnings | Yahoo Finance | Edwards Lifesciences Corporation (EW) Draws Positive Analyst View After Q4 Update - Yahoo Finance |
| 2025-07-25 | +3.2% | legal | SEC EDGAR | EW 8-K: 5.02 (SEC Filing) |
| 2026-02-04 | -3.1% | earnings | Yahoo Finance | Edwards Lifesciences' Q4 Earnings on Deck: Here's What to Expect - Yahoo Finance |
| 2025-12-15 | +3.1% | legal | Seeking Alpha | FDA making use of real-world evidence in device applications easier |
| 2024-04-25 | -3.0% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-02-12 | -2.9% | analyst | TIKR.com | Edwards Lifesciences Stock Gained 9% Last Year: Why Analysts Flag a 75% Upside Case - TIKR.com |
| 2026-02-12 | -2.9% | earnings | Yahoo Finance | How Investors Are Reacting To Edwards Lifesciences (EW) 2026 Guidance After Profit Squeeze In 2025 - Yahoo Finance |
| 2026-04-23 | +2.8% | earnings | Seeking Alpha | Edwards Lifesciences raises 2026 revenue guidance on bullish Q1 results |
| 2026-04-23 | +2.8% | earnings | Seeking Alpha | Edwards Lifesciences Non-GAAP EPS of $0.78 beats by $0.05, revenue of $1.65B beats by $50M |
| 2026-04-23 | +2.8% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-04-23 | +2.8% | earnings | Quiver Quantitative | Edwards Lifesciences (EW) Stock Rises on Q1 2026 Earnings - Quiver Quantitative |
| 2026-04-23 | +2.8% | news | Business Wire | Edwards Lifesciences Reports First Quarter Results - Business Wire |
| 2026-04-23 | +2.8% | earnings | Yahoo Finance | Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics - Yahoo Finance |
| 2026-04-23 | +2.8% | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Releases FY 2026 Earnings Guidance - MarketBeat |
| 2026-04-23 | +2.8% | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat |
| 2026-04-23 | +2.8% | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Releases Q2 2026 Earnings Guidance - MarketBeat |
| 2026-04-23 | +2.8% | earnings | UBND thành phố Hải Phòng | EW (Edwards Lifesciences Corporation) reports Q4 2025 EPS miss, shares climb 2.45 percent amid positive investor sentiment. - Top Analyst Buy Signals - UBND thành phố Hải Phòng |
| 2023-04-26 | -2.8% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2025-04-23 | +2.7% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-01-10 | -2.6% | M&A | Seeking Alpha | Edwards drops JenaValve bid as court sides with FTC to block the deal |
| 2025-10-29 | +2.6% | earnings | Seeking Alpha | Edwards Lifesciences Q3 2025 Earnings Preview |
| 2021-05-05 | -2.5% | legal | SEC EDGAR | EW 8-K: 5.02, 5.07, 7.01 (SEC Filing) |
| 2026-02-13 | +2.4% | executive | Stock Titan | Edwards Lifesciences CFO at Citi medtech, life sciences access day Feb. 26 - Stock Titan |
| 2025-05-08 | -2.4% | legal | SEC EDGAR | EW 8-K: 5.02, 5.07 (SEC Filing) |
| 2025-12-04 | +2.4% | earnings | Seeking Alpha | Edwards Lifesciences 2026 EPS guidance range includes consensus |
| 2026-02-09 | -2.3% | earnings | Seeking Alpha | Edwards Lifesciences Q4 2025 Earnings Preview |
| 2026-02-09 | -2.3% | analyst | Yahoo Finance | What Are Wall Street Analysts' Target Price for Edwards Lifesciences Stock? - Yahoo Finance |
| 2025-10-08 | -2.3% | analyst | Investing.com | Edwards Lifesciences stock downgraded by Oppenheimer on structural concerns - Investing.com |
| 2026-04-16 | +2.1% | earnings | Stock Titan | After the bell April 23, Edwards Lifesciences will discuss Q1 results - Stock Titan |
| 2026-04-16 | +2.1% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Stock Position Lessened by Diversify Advisory Services LLC - MarketBeat |
| 2021-07-29 | +2.1% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-03-03 | -2.1% | news | TIKR.com | Here’s Why Edwards Lifesciences Stock Could Reach $150 - TIKR.com |
| 2025-12-02 | -2.0% | news | Yahoo Finance | How Is Edwards Lifesciences’ Stock Performance Compared to Other Medical Device Stocks? - Yahoo Finance |
| 2026-04-17 | +2.0% | earnings | MarketBeat | Lbp Am Sa Buys 107,330 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-17 | +2.0% | analyst | Investing.com | TD Cowen reiterates Edwards Lifesciences stock rating on TAVR strength - Investing.com |
| 2026-04-17 | +2.0% | earnings | MarketBeat | KBC Group NV Reduces Holdings in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-17 | +2.0% | news | simplywall.st | Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Moves? - simplywall.st |
| 2026-04-17 | +2.0% | earnings | MarketBeat | Fisher Funds Management LTD Decreases Position in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-02-05 | -2.0% | earnings | Yahoo Finance | Ahead of Edwards Lifesciences (EW) Q4 Earnings: Get Ready With Wall Street Estimates for Key Metrics - Yahoo Finance |
| 2022-12-08 | +1.9% | legal | SEC EDGAR | EW 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-10-24 | -1.9% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2026-04-14 | -1.9% | earnings | MarketBeat | Baillie Gifford & Co. Sells 55,936 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-14 | -1.9% | earnings | MarketBeat | Sumitomo Mitsui Trust Group Inc. Sells 39,987 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-14 | -1.9% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Stake Lessened by Robeco Institutional Asset Management B.V. - MarketBeat |
| 2026-04-13 | -1.8% | earnings | MarketBeat | Hardman Johnston Global Advisors LLC Sells 34,124 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-13 | -1.8% | news | DirectorsTalk Interviews | Edwards Lifesciences Corporation (EW) Stock Analysis: Unveiling A 24% Potential Upside - DirectorsTalk Interviews |
| 2026-03-12 | -1.8% | news | Yahoo Finance | How The Edwards Lifesciences (EW) Story Is Shifting As 2026 Expectations Tighten - Yahoo Finance |
| 2026-03-16 | +1.7% | news | Seeking Alpha | Edwards Lifesciences: More Appeal For The Heart |
| 2026-03-16 | +1.7% | news | Yahoo Finance | Edwards Lifesciences (EW) Valuation Check After Recent Share Price Momentum - Yahoo Finance |
| 2026-03-13 | -1.7% | news | Yahoo Finance | Edwards Lifesciences Stock Up 22.1% in a Year: What's Driving It? - Yahoo Finance |
| 2023-12-07 | -1.6% | legal | SEC EDGAR | EW 8-K: 7.01, 8.01 (SEC Filing) |
| 2026-03-21 | -1.6% | news | Yahoo Finance | Is Edwards Lifesciences Corporation (EW) A Good Stock To Buy Now? - Yahoo Finance |
| 2025-12-05 | -1.6% | analyst | Yahoo Finance | Will Edwards Lifesciences’ (EW) Upgraded 2025–2026 Outlook Reshape Its Long-Term Growth Narrative? - Yahoo Finance |
| 2025-11-11 | +1.5% | news | Yahoo Finance | Edwards Lifesciences Stock: Is Wall Street Bullish or Bearish? - Yahoo Finance |
| 2024-03-26 | +1.5% | legal | SEC EDGAR | EW 8-K: 5.02 (SEC Filing) |
| 2026-01-12 | -1.5% | news | Seeking Alpha | Edwards Lifesciences Corporation (EW) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript |
| 2026-03-31 | -1.5% | news | Yahoo Finance | Assessing Edwards Lifesciences (EW) Valuation As Growth Hopes Contrast With Rich P/E Multiple - Yahoo Finance |
| 2025-08-13 | +1.3% | analyst | Yahoo Finance | Edwards Lifesciences Stock: Analyst Estimates & Ratings - Yahoo Finance |
| 2026-03-10 | +1.3% | news | Seeking Alpha | Edwards Lifesciences Corporation (EW) Presents at Barclays 28th Annual Global Healthcare Conference Transcript |
| 2026-01-30 | +1.2% | news | TIKR.com | Edwards Lifesciences Stock: What the Numbers Say After a 15% Gain Last Year - TIKR.com |
| 2026-03-27 | -1.1% | earnings | Yahoo Finance | What to Expect From Edwards Lifesciences' Next Quarterly Earnings Report - Yahoo Finance |
| 2026-01-31 | +1.1% | analyst | Yahoo Finance | Analyst Upgrades Signal Renewed Growth Cycle for Edwards Lifesciences Corporation (EW) - Yahoo Finance |
| 2025-12-23 | -1.1% | legal | Seeking Alpha | Edwards Lifesciences wins FDA nod for SAPIEN M3 TMVR system |
| 2025-10-31 | -1.0% | earnings | Seeking Alpha | Edwards Lifesciences trading flat despite 2025 guidance raise, Q3 beats |
| 2025-10-31 | -1.0% | earnings | Seeking Alpha | Edwards Lifesciences raises 2025 guidance to high end of 9–10% sales growth and $2.56–$2.62 EPS amid strong Q3 |
| 2025-10-31 | -1.0% | earnings | Seeking Alpha | Edwards Lifesciences Corporation (EW) Q3 2025 Earnings Call Transcript |
| 2026-01-14 | +1.0% | news | Yahoo Finance | Edwards Lifesciences (EW) Valuation Check As Recent Share Momentum Meets Premium P/E Pricing - Yahoo Finance |
| 2026-01-14 | +1.0% | news | Zacks Investment Research | Is it Apt to Hold Edwards Lifesciences Stock in Your Portfolio Now? - Zacks Investment Research |
| 2026-01-19 | +1.0% | earnings | Yahoo Finance | Does Edwards Lifesciences (EW) Have Strong Double-Digit Earnings Potential? - Yahoo Finance |
| 2026-01-19 | +1.0% | news | Yahoo Finance | What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing? - Yahoo Finance |
| 2022-07-21 | +1.0% | legal | SEC EDGAR | EW 8-K: 1.01, 1.02, 2.03 (SEC Filing) |
| 2021-10-27 | -0.9% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2024-07-10 | -0.8% | legal | SEC EDGAR | EW 8-K: 5.02 (SEC Filing) |
| 2026-04-06 | -0.8% | news | Stock Titan | Edwards Lifesciences (EW) CVP exercises options and sells 1,019 shares under 10b5-1 plan - Stock Titan |
| 2026-02-11 | +0.8% | earnings | Seeking Alpha | Edwards Lifesciences outlines 8%–10% sales growth and $2.90–$3.05 EPS guidance for 2026 while advancing SAPIEN and TMTT platforms |
| 2026-02-11 | +0.8% | earnings | Seeking Alpha | Edwards Lifesciences Corporation (EW) Q4 2025 Earnings Call Transcript |
| 2026-02-11 | +0.8% | news | Investor's Business Daily | Heart-Valve Maker Comes Up Mixed, But Offer Bullish View - Investor's Business Daily |
| 2026-04-19 | +0.8% | earnings | MarketBeat | Lecap Asset Management Ltd. Invests $1.07 Million in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-19 | +0.8% | earnings | MarketBeat | Birch Hill Investment Advisors LLC Sells 13,385 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-18 | +0.8% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Shares Bought by Ninety One SA Pty Ltd - MarketBeat |
| 2026-04-18 | +0.8% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Shares Sold by Ninety One UK Ltd - MarketBeat |
| 2026-04-18 | +0.8% | earnings | MarketBeat | Ninety One North America Inc. Has $48.42 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-20 | -0.7% | earnings | MarketBeat | TriaGen Wealth Management LLC Invests $4.55 Million in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-20 | -0.7% | earnings | MarketBeat | Mirae Asset Global Investments Co. Ltd. Increases Holdings in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-20 | -0.7% | earnings | TradingView | Edwards Lifesciences' Q1 Earnings on Deck: Here's What to Expect - TradingView |
| 2026-04-20 | -0.7% | news | DirectorsTalk Interviews | Edwards Lifesciences Corporation (EW) Stock Analysis: A High-Stakes Bet in Medical Devices with 18.94% Upside - DirectorsTalk Interviews |
| 2026-04-02 | -0.6% | earnings | MarketBeat | Donald Bobo Jr Sells 22,680 Shares of Edwards Lifesciences (NYSE:EW) Stock - MarketBeat |
| 2026-04-02 | -0.6% | news | Stock Titan | Edwards Lifesciences (EW) VP sells 22,680 shares after option exercise - Stock Titan |
| 2026-04-02 | -0.6% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Shares Sold by Nisa Investment Advisors LLC - MarketBeat |
| 2026-04-02 | -0.6% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Shares Bought by Allspring Global Investments Holdings LLC - MarketBeat |
| 2026-04-22 | -0.6% | earnings | Seeking Alpha | Edwards Lifesciences Q1 2026 Earnings Preview |
| 2026-04-22 | -0.6% | earnings | MarketBeat | Universal Beteiligungs und Servicegesellschaft mbH Acquires 21,165 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-22 | -0.6% | earnings | simplywall.st | How Edwards' TAVR and TMTT Momentum Heading Into Q1 2026 (EW) Has Changed Its Investment Story - simplywall.st |
| 2026-04-22 | -0.6% | earnings | Cổng thông tin điện tử Tỉnh Sơn La | EW (Edwards Lifesciences Corporation) reports Q4 2025 EPS miss, shares climb 2.45 percent amid positive investor sentiment. - Hot Momentum Watchlist - Cổng thông tin điện tử Tỉnh Sơn La |
| 2025-11-01 | +0.6% | analyst | Seeking Alpha | Notable analyst calls this week: Meta, Boeing and Comcast among top picks |
| 2026-03-02 | -0.6% | news | Seeking Alpha | Edwards Lifesciences Corporation (EW) Presents at TD Cowen 46th Annual Health Care Conference Transcript |
| 2026-03-02 | -0.6% | legal | DirectorsTalk Interviews | Edwards Lifesciences (EW) Stock Analysis: Evaluating a Potential 11.56% Upside in the Healthcare Sector - DirectorsTalk Interviews |
| 2024-02-06 | -0.5% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2025-10-30 | +0.5% | executive | Seeking Alpha | Edwards Lifesciences CFO to step down by mid-2026 |
| 2025-10-30 | +0.5% | earnings | Seeking Alpha | Edwards Lifesciences Non-GAAP EPS of $0.67 beats by $0.08, revenue of $1.55B beats by $50M |
| 2025-10-30 | +0.5% | legal | SEC EDGAR | EW 8-K: 5.02, 7.01 (SEC Filing) |
| 2025-10-30 | +0.5% | legal | SEC EDGAR | EW 8-K: 2.02 and (SEC Filing) |
| 2024-06-03 | +0.4% | legal | SEC EDGAR | EW 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-12-18 | -0.4% | analyst | Seeking Alpha | Edwards Lifesciences upgraded at JP Morgan on TAVR, TMTT strength |
| 2026-04-01 | +0.4% | earnings | MarketBeat | Edwards Lifesciences Corporation $EW Shares Acquired by J. Safra Sarasin Holding AG - MarketBeat |
| 2026-04-01 | +0.4% | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Raised to Outperform at Wolfe Research - MarketBeat |
| 2024-06-17 | +0.4% | legal | SEC EDGAR | EW 8-K: 5.02 (SEC Filing) |
| 2026-04-05 | -0.3% | earnings | MarketBeat | Nvwm LLC Has $1.46 Million Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-04 | -0.3% | earnings | MarketBeat | Edwards Lifesciences Corporation (NYSE:EW) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat |
| 2026-03-11 | +0.3% | news | Seeking Alpha | Edwards Lifesciences Corporation (EW) Presents at Leerink Global Healthcare Conference 2026 Transcript |
| 2025-12-29 | -0.3% | news | Seeking Alpha | The Edwards Lifesciences Dilemma Persists: Strong Growth Potential, High Price |
| 2023-05-15 | -0.3% | legal | SEC EDGAR | EW 8-K: 5.02, 5.03, 5.07 (SEC Filing) |
| 2026-04-21 | -0.2% | earnings | MarketBeat | Zurcher Kantonalbank Zurich Cantonalbank Buys 23,305 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2025-12-11 | -0.2% | analyst | Seeking Alpha | Edwards Lifesciences Corporation (EW) Analyst/Investor Day Transcript |
| 2026-04-15 | +0.1% | earnings | MarketBeat | Edwards Lifesciences (EW) Expected to Announce Quarterly Earnings on Wednesday - MarketBeat |
| 2022-11-01 | +0.0% | legal | SEC EDGAR | EW 8-K: 8.01 and (SEC Filing) |
| 2026-04-26 | — | news | simplywall.st | Is Edwards Lifesciences (EW) Still Attractive After Recent Share Price Rebound? - simplywall.st |
| 2026-04-25 | — | earnings | MarketBeat | Munich Reinsurance Co Stock Corp in Munich Purchases 52,494 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-24 | — | earnings | Zacks | EW's Q1 Earnings Beat, Revenues Match, '26 View Up, Stock Climbs |
| 2026-04-24 | — | analyst | MT Newswires | Mizuho Securities Adjusts Edwards Lifesciences Price Target to $100 From $95, Maintains Outperform Rating |
| 2026-04-24 | — | earnings | Medical Device Network | Edwards Lifesciences raises FY26 guidance following strong Q1 |
| 2026-04-24 | — | analyst | MT Newswires | Truist Securities Adjusts Price Target on Edwards Lifesciences to $90 From $89, Maintains Hold Rating |
| 2026-04-24 | — | earnings | Investor's Business Daily | The 'Standout' From Edwards Lifesciences' Broad-Based Sales Beat |
| 2026-04-24 | — | news | MedTech Dive | Edwards raises 2026 forecast as TAVR sales surge |
| 2026-04-24 | — | analyst | MT Newswires | Bernstein Adjusts PT on Edwards Lifesciences to $96 From $95, Maintains Market Perform Rating |
| 2026-04-24 | — | analyst | MT Newswires | Canaccord Genuity Adjusts PT on Edwards Lifesciences to $85 From $87, Maintains Hold Rating |
| 2026-04-24 | — | analyst | MT Newswires | Barclays Adjusts PT on Edwards Lifesciences to $110 From $104, Maintains Overweight Rating |
| 2026-04-24 | — | analyst | MT Newswires | Evercore ISI Adjusts PT on Edwards Lifesciences to $93 From $92, Maintains Outperform Rating |
| 2026-04-24 | — | earnings | Seeking Alpha | Edwards forecasts 9%-11% 2026 sales growth and $2.95-$3.05 adjusted EPS as TAVR guide rises to 7%-9% |
| 2026-04-24 | — | earnings | Seeking Alpha | Edwards Lifesciences Corporation (EW) Q1 2026 Earnings Call Transcript |
| 2026-04-24 | — | news | Investor's Business Daily | Investors Show Some Love To This Heart-Healthy Stock - Investor's Business Daily |
| 2026-04-24 | — | news | Benzinga | Edwards Lifesciences Stock Surges On Heart Valve Devices Growth - Benzinga |
| 2026-04-24 | — | news | ChartMill | EW Stock Price, Quote & Chart | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill |
| 2026-04-24 | — | analyst | Investing.com | Truist raises Edwards Lifesciences stock price target on TAVR growth - Investing.com |
| 2026-04-24 | — | earnings | MarketBeat | OLD National Bancorp IN Sells 16,066 Shares of Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-24 | — | news | ChartMill | EW Technical Analysis | Trend, Signals & Chart Patterns | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill |
| 2026-04-24 | — | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at BTIG Research - MarketBeat |
| 2026-04-24 | — | earnings | Investing.com Australia | BTIG raises Edwards Lifesciences stock price target on strong Q1 beat - Investing.com Australia |
| 2026-04-24 | — | earnings | MarketBeat | Edwards Lifesciences (NYSE:EW) Given New $87.00 Price Target at Robert W. Baird - MarketBeat |
| 2026-04-24 | — | earnings | MarketBeat | Teacher Retirement System of Texas Has $23.75 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat |
| 2026-04-24 | — | analyst | Investing.com Canada | Bernstein SocGen raises Edwards Lifesciences stock price target to $96 By Investing.com - Investing.com Canada |
| 2026-04-24 | — | earnings | Investing.com UK | Stifel reiterates Edwards Lifesciences stock rating on strong Q1 beat - Investing.com UK |
| 2026-04-24 | — | earnings | Investing.com India | BTIG raises Edwards Lifesciences stock price target on strong Q1 beat By Investing.com - Investing.com India |
| 2026-04-24 | — | analyst | Investing.com India | Canaccord cuts Edwards Lifesciences stock price target on valuation By Investing.com - Investing.com India |